Illumina Inc. lodged an intent to appeal Wednesday with the Fifth Circuit as it fights a Federal Trade Commission order calling for the DNA sequencing provider to unwind its $8 billion reacquisition of cancer-testing outfit Grail Inc. and asked the court to move quickly.
Willis-Knighton Medical Center has urged the U.S. Supreme Court not to hear a case alleging it interfered with another hospital operator's relationship with Louisiana State University, saying the lower courts were right to find the school had good reason to terminate the affiliation.
Media conglomerate Vivendi has offered Europe's competition enforcer a new package of fixes over concerns raised about the impact its planned purchase of Lagardere could have on celebrity magazine and French-language book publishing.
The leaders of the U.S. Department of Justice's Antitrust Division and the Federal Trade Commission each said Monday that enforcers are looking closely at artificial intelligence and competition issues that might develop in the emerging field.
Carl Icahn told Illumina shareholders on Friday the circumstances surrounding the company's decision to close its $8 billion deal for Grail despite objections from antitrust regulators represents "a new low in corporate governance," continuing to push for a board shakeup.